Aveanna Healthcare (NASDAQ:AVAH) Stock Price Expected to Rise, UBS Group Analyst Says
Aveanna Healthcare (NASDAQ:AVAH – Get Free Report) had its price objective increased by UBS Group from $4.50 to $5.00 in a report released on Friday,Benzinga reports. The brokerage presently has a “sell” rating on the stock. UBS Group’s target price suggests a potential downside of 7.75% from the stock’s previous close. Separately, Truist Financial lowered […]
Aveanna Healthcare (NASDAQ:AVAH – Get Free Report) had its price objective increased by UBS Group from $4.50 to $5.00 in a report released on Friday,Benzinga reports. The brokerage presently has a “sell” rating on the stock. UBS Group’s target price suggests a potential downside of 7.75% from the stock’s previous close. Separately, Truist Financial lowered […]
